
Unitex Tenamyd Canada Private Limited
About Unitex Tenamyd Canada Private Limited
Data last updated:
Unitex Tenamyd Canada Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Srs Pharmaceuticals Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 June 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2006PTC162913. Its GSTIN is 27AAACU9293Q1ZC (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suchet Shyamsunder Rastogi and Rajan Dubey.
Its last annual general meeting (AGM) was held on 19 August 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 504 Marathon Max Bldg No.2 Mulund – Goregoan Link L.B.S Marg Mulund West Mumbai Mh 400080, In, Maharashtra, India – 400080.
As per the financials filed for FY 2021, the company reported a revenue of ₹2.34 Lakh, a decline of 76% compared to the previous year. For the same year it recorded a net profit of ₹14,025 (net margin 6%) and EBITDA of ₹19,940 (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 51% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Unitex Tenamyd Canada Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address504 Marathon Max Bldg No.2 Mulund – Goregoan Link L.B.S Marg Mulund West Mumbai Mh 400080, In, Maharashtra, India – 400080
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Unitex Tenamyd Canada Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Unitex Tenamyd Canada Private Limited
FY 2021 filings availableUnitex Tenamyd Canada Private Limited reported revenue of ₹2.34 Lakh (down 76% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue fell 76% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 51%. EBITDA fell 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.34 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19,940 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14,025 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | 6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unitex Tenamyd Canada Private Limited, buy the company report.
Board of directors of Unitex Tenamyd Canada Private Limited
Unitex Tenamyd Canada has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suchet Shyamsunder Rastogi Also directs: SRS Unistraw Private Limited, Clesstra Healthcare Private Limited, SRS Pharmaceuticals Private Limited and 3 more | Director | 29 Jun 2006 | 20 Years 4 Months | Current |
| Rajan Dubey Also directs: SRS Unistraw Private Limited, Clesstra Healthcare Private Limited, SRS Therapeutics Private Limited and 5 more | Director | 06 Feb 2020 | 6 Years 9 Months | Current |
Peer comparison
Unitex Tenamyd Canada Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Valtin Healthcare Private Limited | ₹2.38 Lakh (FY 2018) | New Delhi, Delhi, India | ||||
| Ambrosia Wellness Private Limited | ₹2.38 Lakh (FY 2025) | 6.0% | Hyderabad, Telangana, India | |||
| Life Plus Pharmaceuticals Private Limited | ₹2.38 Lakh (FY 2021) | Mumbai, Maharashtra, India | ||||
| Ritesh Health-Care Private Limited | ₹2.35 Lakh (FY 2022) | Delhi, India | ||||
| Evehica Pharmaceutical Private Limited | ₹2.35 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Unitex Tenamyd Canada Private Limitedthis company | ₹2.34 Lakh (FY 2021) | ₹14,025 | 6% | -76.0% | Mumbai, Maharashtra, India | |
| Hargo Pharm Private Limited | ₹2.33 Lakh (FY 2017) | 107.0% | Thane, Maharashtra, India | |||
| Systems Bio-Medical (India) Pvt Ltd | ₹2.32 Lakh (FY 2025) | -68.0% | Mumbai, Maharashtra, India | |||
| Entod Healthcare Private Limited | ₹2.31 Lakh (FY 2025) | 12.0% | Mumbai, Maharashtra, India | |||
| Srivu Life Science Private Limited | ₹2.3 Lakh (FY 2025) | -29.0% | Patna, Bihar, India | |||
| Sirsha Wellness Private Limited | ₹2.3 Lakh (FY 2025) | Miraj, Maharashtra, India |
To see the full peer comparison of Unitex Tenamyd Canada Private Limited, buy the company report.
Auditor
Unitex Tenamyd Canada Private Limited is audited by M SHETH & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M SHETH & CO | FY 2021 | 116371W |
Shareholding
The shareholding of Unitex Tenamyd Canada Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unitex Tenamyd Canada Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unitex Tenamyd Canada Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unitex Tenamyd Canada Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unitex Tenamyd Canada has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACU9293Q1ZC | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unitex Tenamyd Canada Private Limited, buy the company report.
Recent activity
Unitex Tenamyd Canada Private Limited has 6 board changes on record since 2006: 2 appointments and 4 cessations. The latest: Rajan Dubey ceased to be Additional Director on 30 Dec 2020.
Frequently asked questions
Unitex Tenamyd Canada is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 June 2006 (20+ years old) and is registered under CIN U24239MH2006PTC162913.
Unitex Tenamyd Canada has 2 current directors:
- Suchet Shyamsunder Rastogi - Director
- Rajan Dubey - Director
The latest financial statements of Unitex Tenamyd Canada on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 19 August 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Unitex Tenamyd Canada is 27AAACU9293Q1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Unitex Tenamyd Canada is U24239MH2006PTC162913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unitex Tenamyd Canada was incorporated on 29 June 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Unitex Tenamyd Canada by revenue are Valtin Healthcare Private Limited, Ambrosia Wellness Private Limited, Life Plus Pharmaceuticals Private Limited, Ritesh Health-Care Private Limited, Evehica Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Rajan Dubey ceased to be Additional Director on 30 Dec 2020. Ratnakar Pandarinath Mehendre ceased to be Director on 31 Mar 2020. Rajan Dubey was appointed as Director on 06 Feb 2020. Unitex Tenamyd Canada has 6 board changes on record in total.
The registered office of Unitex Tenamyd Canada is at 504 Marathon Max Bldg No.2 Mulund – Goregoan Link L.B.S Marg Mulund West Mumbai Mh 400080, In, Maharashtra, India – 400080.
Unitex Tenamyd Canada operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Unitex Tenamyd Canada is compliant as of 05 September 2026. The company is actively filing with the Registrar of Companies.

